KMDAKamada Ltd.
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Rangebound, no clear trend. Oversold (RSI 23). Price is −2% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How KMDA is trading
Kamada Ltd. is +21% over the past year while the S&P 500 is +18%: 2.3 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −1.7%
vs 200-day average · below trend, but not far
- RSI (14)
- 23
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 14%
Below its 52-week high
Details›
- Last close2026-10-08
- $7.78
- 1 monthS&P 500 +1.6%
- −5.0%
- 1 yearS&P 500 +18%
- +21%
- 5 yearsS&P 500 +86%
- +56%
- vs 50-day average$8.05
- −3.3%
- 52-week high
- $9.04
- 52-week low
- $6.41
- Annualised volatility
- 36%
| Year | Return |
|---|---|
| 2026 (year to date) | +14% |
| 2025 | +19% |
| 2024 | −0.49% |
| 2023 | +53% |
| 2022 | −39% |
| 2021 | +1.5% |
| 2020 | −5.1% |
| 2019 | +37% |
| 2018 | +5.3% |
| 2017 | −13% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +6.0% |
| Feb | 10 | 5 of 10 | +1.0% |
| Mar | 10 | 3 of 10 | −2.7% |
| Apr | 10 | 5 of 10 | +2.1% |
| May | 10 | 5 of 10 | −0.77% |
| Jun | 10 | 4 of 10 | −0.18% |
| Jul | 11 | 6 of 11 | +2.0% |
| Aug | 11 | 6 of 11 | +4.9% |
| Sep | 11 | 5 of 11 | −2.7% |
| Oct | 11 | 5 of 11 | −2.3% |
| Nov | 10 | 5 of 10 | +5.0% |
| Dec | 10 | 5 of 10 | +1.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #10 of 41 by RyuScore